← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2024-01-11

Drug application

FDA Application #

ANDA217348

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

OXALIPLATIN

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MEITHEAL

Manufacturer

Meitheal Pharmaceuticals Inc.

First approval

2024-01-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown